Takeda Pharmaceutical Company Limited (TAK) stock analysis
In our weekly check, Takeda Pharmaceutical Company Limited is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 16 pass, warnings: 7, red flags: 2.
About Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in Japan, listed on NYSE as TAK.
What our checks show for TAK
Red flags
- The gross margin fell by 9.6 points, to 59.4%: costs are rising faster than prices.
- Return on capital (ROCE) is only 4.9%.
Warning signs
- Net debt is 3.1x a year of EBITDA (debt/equity 0.62). That limits room in a downturn and raises refinancing risk.
- Operating profit covers interest only 2.2 times: a weak year could make the payments hard.
- Analysts expect only about 2.1% a year of growth in revenue.
- The net margin is only 8.2%: little room if costs rise.
- The dividend takes 82% of profit: little cushion if profit falls.
- The stock has fallen as much as 60% from a peak. Would you have held through that?
- The stock is still below its previous peak.
Strengths
- The net margin rose by 1.7 points over 5 years, to 8.2%.
- Operating cash flow is 2.15x net profit: the profit arrives as real cash.
- A large company: market value $67.61 billion.
- Beta 0.09: the stock usually moves less than the market.
- Actively traded: about 2.6 million shares a day.
- Pay in shares is only 12.4% of free cash flow.
Next earnings report: 2027-01-28
Similar companies
TEVA · HLN · ZTS · VTRS · ELAN · ALKS
Questions
What grade does Takeda Pharmaceutical Company Limited (TAK) have?
In our weekly check, Takeda Pharmaceutical Company Limited is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 16 pass, warnings: 7, red flags: 2. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of TAK stock?
This week's biggest flags for Takeda Pharmaceutical Company Limited: Gross margin falling, Low return on capital, High debt. In total 9 of 25 checks show a warning or a red flag.
What does Takeda Pharmaceutical Company Limited do?
Takeda Pharmaceutical Company Limited is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in Japan, listed on NYSE as TAK.
When does Takeda Pharmaceutical Company Limited report earnings next?
The next earnings report is expected on 2027-01-28. We re-run the checks every week, so the grade can change after it.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis